RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue
+25.0%
EPS
−47.4%
Free cash flow
−43.2%
Total debt
+21.2%

Quarter to June 2026, against a year earlier

75.66 2.35 −3.01%
Market cap
$6.1B
P/E
0.0×
Fwd P/E
1,050×
Dividend yield
—
F-score
3/9
Altman Z
2.04
Beneish M
−2.62
Dividend safety
n/a

RadNet, Inc. (RDNT) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, RadNet, Inc. (RDNT) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 0.9× (March 2020) to 3.8× (November 2024); the current reading is higher than 92% of that period. That is below the Diagnostics & Research industry median of 5.2× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.8× (5.14%)
FY2024 2.9× 73.28%
FY2023 1.7× 32.48%
FY2022 1.3× (25.72%)
FY2021 1.7× 14.34%
FY2020 1.5× 0.67%
FY2019 1.5× 31.31%
FY2018 1.1× 5.70%
FY2017 1.1× 6.96%
FY2016 1.0× (6.84%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.4× 3.35%
Mar 2026 2.3× (17.35%)
Dec 2025 2.8× (9.68%)
Sep 2025 3.1× 30.85%
42 more quarters

Against its own ten years

Low 0.9× High 3.8×
Ten-year median 1.4×
Current reading's percentile 92

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 2.4×
RDNT RadNet, Inc. 2.9×
CRL Charles River Laboratories International, Inc. compare 4.6×
SHC Sotera Health Company compare 5.2×
QGEN QIAGEN N.V. compare 5.3×
CDNA CareDx, Inc. compare 7.7×
BLLN BillionToOne, Inc. compare 11.2×
ADPT Adaptive Biotechnologies Corporation compare 15.2×
GRAL GRAIL, Inc. compare 28.8×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RDNT